Evidence map›Paper›PMID 31931605›Full record

ArticleHealth communication2021

Deliberation and Valence as Dissociable Components of Counterarguing among Smokers: Evidence from Neuroimaging and Quantitative Linguistic Analysis.

Jiaying Liu, Matthew B O'Donnell, Emily B Falk

Abstract read
In one paragraph

Article in Health communication, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Diminished valuation in the brain: how repeated exposure reduces health message engagement.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jiaying LiuDepartment of Communication Studies, University of Georgia.ORCID 0000-0001-8461-0954
Matthew B O'DonnellAnnenberg School for Communication, University of Pennsylvania.
Emily B FalkAnnenberg School for Communication, University of Pennsylvania.

Funding

UPENN TCORS: Tobacco Product Messaging in a Complex Communication EnvironmentP50CA179546 · NCI · UNIVERSITY OF PENNSYLVANIA · PI HORNIK, ROBERT C., LERMAN, CARYN · 2013 to 2017
$18.7M
Can neuroscience dramatically improve our ability to design health communicationsDP2DA035156 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI FALK, EMILY · 2012 to 2012
$2.3M
NCI NIH HHS P50 CA179546NIDA NIH HHS DP2 DA035156
6 · The paper itself

Abstract

Counterarguing is a key obstacle to successful persuasion. However, the difficulty of directly measuring counterarguing during message exposure limits knowledge of the underlying mechanisms. The current study combines neuroimaging and linguistic measures to unpack neurocognitive and psychological mechanisms associated with counterarguing among a sample of established smokers in response to anti-smoking messaging. We capture participants' neural activity in brain regions associated with effortful deliberation and negative argumentation during message exposure, and link it with their subsequent language patterns to further understanding of counterarguing in the brain. Greater brain activity within key regions of interest associated with deliberation and negative argumentation is associated with greater cognitive depth and less positivity in the post-scan message descriptions, respectively, among those who have lower intention to change their smoking behavior. We connect these neural representations of counterarguing with psychological theories and discuss implications that may increase the impact of persuasive communications.

Indexed as

Persuasive CommunicationSmokersHumansIntentionLinguisticsNeuroimaging

Identifiers

PMID31931605
PMCPMC7354887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.